Actinium Pharmaceuticals (ATNM) Change in Cash (2010 - 2026)
Actinium Pharmaceuticals (ATNM) posted quarterly Change in Cash of -$5.9 million for Q1 2026, up 22.6% year-over-year from -$4.8 million in Q1 2025, and down 8.79% quarter-over-quarter from -$5.4 million in Q4 2025.
Actinium Pharmaceuticals (ATNM) Change in Cash (2010 - 2026) Analysis & Trends
Actinium Pharmaceuticals (ATNM) has reported Change in Cash for 16 consecutive years, with -$5.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 22.6% year-over-year to -$5.9 million; the TTM figure through Mar 2026 stood at -$23.2 million (down 23.83% YoY), while the FY2025 annual figure was -$24.9 million, down 561.75% from the prior year.
- Change in Cash eased to -$5.9 million in Q1 2026 per ATNM's latest filing, from -$5.4 million in the prior quarter.
- Across five years, Change in Cash topped out at $44.3 million in Q2 2022 and bottomed at -$14.4 million in Q1 2023.
- Historically, Change in Cash has averaged -$2.1 million across 5 years, with a median of -$5.8 million in 2024.
- On a YoY basis, Change in Cash climbed as much as 358.75% in 2022 and fell as far as 3610.83% in 2022.
- Actinium Pharmaceuticals' Change in Cash stood at -$2.9 million in 2022, then sank by 117.1% to -$6.3 million in 2023, then increased by 8.64% to -$5.8 million in 2024, then grew by 6.33% to -$5.4 million in 2025, then fell by 8.79% to -$5.9 million in 2026.
- Business Quant data shows ATNM's Change in Cash at -$5.9 million in Q1 2026, -$5.4 million in Q4 2025, and -$6.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Actinium Pharmaceuticals | 35.01 Mn | 35.01 Mn | - | -5.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.66 Mn |
| Mar 31, 2026 | -5.86 Mn |
| Dec 31, 2025 | -5.39 Mn |
| Sep 30, 2025 | -6.53 Mn |
| Jun 30, 2025 | -5.40 Mn |
| Mar 31, 2025 | -7.58 Mn |
| Dec 31, 2024 | -5.75 Mn |
| Sep 30, 2024 | -7.37 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 7.38 Mn |
| Dec 31, 2023 | -6.30 Mn |
| Sep 30, 2023 | -8.30 Mn |
| Jun 30, 2023 | -3.64 Mn |
| Mar 31, 2023 | -14.38 Mn |
| Dec 31, 2022 | -2.90 Mn |
| Sep 30, 2022 | -4.21 Mn |
| Jun 30, 2022 | 44.31 Mn |
| Mar 31, 2022 | -5.81 Mn |
| Dec 31, 2021 | -4.25 Mn |
| Sep 30, 2021 | 120,000.00 |